LENKA DRAGER: Open Payments
NPI 1487425849 · OAK HARBOR, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 20 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $873 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Novo Nordisk Inc | 3 | $64 |
| ABBVIE INC. | 2 | $51 |
| Lilly USA, LLC | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Exact Sciences Corporation | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: REXULTI, VRAYLAR, MOUNJARO, Ozempic, Auvelity, TRELEGY ELLIPTA, Cologuard Collection Kit, Veozah.
Industry payments across WA — which companies pay providers there.
